For subcutaneous use.
Dosage and treatment schedule
The recommended dose is 0.5-1.0 mg/kg bodyweight, once a month.
For dogs weighing <5.0 kg:
Aseptically withdraw 0.1 ml/kg from a single 5 mg/ml vial and administer subcutaneously.
For dogs between 5 and 60 kg administer the entire content of the vial (1 ml) according to the table below:
| LIBRELA strength (mg) to be administered |
Bodyweight (kg) of dog | 5 | 10 | 15 | 20 | 30 |
5.0 - 10.0 | 1 vial | | | | |
10.1 - 20.0 | | 1 vial | | | |
20.1 - 30.0 | | | 1 vial | | |
30.1 - 40.0 | | | | 1 vial | |
40.1 - 60.0 | | | | | 1 vial |
60.1 - 80.0 | | | | 2 vials | |
80.1 - 100.0 | | | | 1 vial | 1 vial |
100.1 - 120.0 | | | | | 2 vials |
For dogs above 60 kg, the contents of more than one vial are required to administer a single dose. In those cases, withdraw the content from each required vial into the same syringe and administer as a single subcutaneous injection (2 ml).